Demonstrates surface activity of recombinant myeloperoxidase in yeast, suggesting new biocatalytic applications.
Human myeloperoxidase (hMPO) catalyzes the conversion of hydrogen peroxide and chloride into hypochlorous acid and plays a key role in human immunity. While commercial MPO is typically purified from human blood or produced recombinantly in mammalian cells or E. coli , we present novel approach for producing active recombinant hMPO (rhMPO) in Pichia pastoris . To eliminate the need for enzyme coupling, we engineered a chimeric protein by combining glucose oxidase from Penicillium amagasakiense and rhMPO. The two open reading frames were fused by PCR, yielding a bifunctional enzyme capable of generating hypochlorous acid directly from glucose. Additionally, the enzymes were immobilized on silicone model substrates via adsorption from solution to generate surface activity. This yeast-based production system provides a cost-effective and scalable platform for large-scale MPO synthesis, opening the development of novel biocatalytic applications.
No takes yet. Share an insight, caveat, or question.
Ymbe et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: